Arda CEO Adam Freund recently talked with Grant Belgard at The Bioinformatics CRO about Arda's strategy of eliminating pathogenic cells to treat chronic diseases, our vision of extending healthy lifespan, and some of the battle scars that come from building a biotech startup. Listen to the podcast here:
